Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 8,150 CRVO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | CervoMed Inc. (CRVO) | Grant/Award | 8,150 | n/a |
| Mar 6, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Sale | 114 | $36.4K |
| Mar 5, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,769 | n/a |
| Mar 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 1,908 | n/a |
| Feb 18, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,579 | n/a |
| Jan 14, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 6,193 | n/a |
| Oct 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,108 | n/a |
| Aug 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,644 | n/a |
| Jun 25, 2025 | CervoMed Inc. (CRVO) | Grant/Award | 8,100 | n/a |
| Mar 5, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 15,117 | n/a |